Literature DB >> 18751897

Generalized log-gamma regression models with cure fraction.

Edwin M M Ortega1, Vicente G Cancho, Gilberto A Paula.   

Abstract

In this paper, the generalized log-gamma regression model is modified to allow the possibility that long-term survivors may be present in the data. This modification leads to a generalized log-gamma regression model with a cure rate, encompassing, as special cases, the log-exponential, log-Weibull and log-normal regression models with a cure rate typically used to model such data. The models attempt to simultaneously estimate the effects of explanatory variables on the timing acceleration/deceleration of a given event and the surviving fraction, that is, the proportion of the population for which the event never occurs. The normal curvatures of local influence are derived under some usual perturbation schemes and two martingale-type residuals are proposed to assess departures from the generalized log-gamma error assumption as well as to detect outlying observations. Finally, a data set from the medical area is analyzed.

Mesh:

Year:  2008        PMID: 18751897     DOI: 10.1007/s10985-008-9096-y

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  4 in total

1.  Flexible Cure Rate Modeling Under Latent Activation Schemes.

Authors:  Freda Cooner; Sudipto Banerjee; Bradley P Carlin; Debajyoti Sinha
Journal:  J Am Stat Assoc       Date:  2007-06-01       Impact factor: 5.033

2.  Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models.

Authors:  A D Tsodikov; J G Ibrahim; A Y Yakovlev
Journal:  J Am Stat Assoc       Date:  2003-12-01       Impact factor: 5.033

3.  Assessing influence in regression analysis with censored data.

Authors:  L A Escobar; W Q Meeker
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

4.  Local influence in linear mixed models.

Authors:  E Lesaffre; G Verbeke
Journal:  Biometrics       Date:  1998-06       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.